Skip to content

13F-HR filed by Matrix Capital Management Company, LP

Matrix Capital Management Company, LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 17 holding rows worth $5,238,164,235.

Accession
0001172661-23-000789
Filed
2023-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 17 entries on the cover page, a total value of $5,238,164,235 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,238,164,235 with VALUE read as dollars as filed, 13F file number 028-12595. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GLOBALFOUNDRIES INCG39387108ORDINARY SHARES18,498,000$996,857,220dollars as filed
NVIDIA Corp67066G104COM5,073,000$741,368,220dollars as filed
TRANSDIGM GROUP INC COM893641100Stock1,094,900$689,403,785dollars as filed
ALTAIR ENGINEERING INC021369103COMMON STOCK10,871,000$494,304,370dollars as filed
Amazon.com, Inc023135106COM5,085,000$427,140,000dollars as filed
Applied Materials,Inc.038222105COM4,269,000$415,715,220dollars as filed
Qualcomm Incorporated747525103COM3,337,360$366,909,358dollars as filed
ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHSN07059210STOK497,200$271,670,080dollars as filed
WORKDAY INC CL A98138H101Stock1,586,043$265,392,575dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK9,199,973$185,287,456dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock11,572,590$88,414,588dollars as filed
ZSCALERINC98980G102STOK650,000$72,735,000dollars as filed
PERIMETER SOLUTIONS SAL7579L106COMMON STOCK-FO7,462,500$68,207,250dollars as filed
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR38,974,185$56,902,310dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK5,362,870$56,310,135dollars as filed
Energy Select Sector SPDR Fund81369Y506SHS349,400$30,562,018dollars as filed
Ventyx Biosciences Inc92332V107Common Stock335,000$10,984,650dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-23-000789this filing2023-02-13acceptance time not in the bulk data set